These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2047690)

  • 21. Activities of therapeutic agents and myristamidopropyl dimethylamine against Acanthamoeba isolates.
    Kilvington S; Hughes R; Byas J; Dart J
    Antimicrob Agents Chemother; 2002 Jun; 46(6):2007-9. PubMed ID: 12019127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opportunistic amoebae: challenges in prophylaxis and treatment.
    Schuster FL; Visvesvara GS
    Drug Resist Updat; 2004 Feb; 7(1):41-51. PubMed ID: 15072770
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Shing B; Balen M; McKerrow JH; Debnath A
    Expert Rev Anti Infect Ther; 2021 Nov; 19(11):1427-1441. PubMed ID: 33929276
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide.
    Larkin DF; Kilvington S; Dart JK
    Ophthalmology; 1992 Feb; 99(2):185-91. PubMed ID: 1553206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis.
    Polat ZA; Walochnik J; Obwaller A; Vural A; Dursun A; Arici MK
    Clin Exp Ophthalmol; 2014 Mar; 42(2):151-8. PubMed ID: 23601234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial action of biguanides on the viability of Acanthamoeba cysts and assessment of cell toxicity.
    Mafra CS; Carrijo-Carvalho LC; Chudzinski-Tavassi AM; Taguchi FM; Foronda AS; Carvalho FR; de Freitas D
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6363-72. PubMed ID: 23900604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Development of Drugs against Acanthamoeba Infections.
    Siddiqui R; Aqeel Y; Khan NA
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6441-6450. PubMed ID: 27600042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weak cytotoxic activity of miltefosine against clinical isolates of Acanthamoeba spp.
    Mrva M; Garajová M; Lukáč M; Ondriska F
    J Parasitol; 2011 Jun; 97(3):538-40. PubMed ID: 21506779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment.
    Visvesvara GS
    Curr Opin Infect Dis; 2010 Dec; 23(6):590-4. PubMed ID: 20802332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acanthamoeba keratitis: report of three cases.
    Maudgal PC
    Bull Soc Belge Ophtalmol; 1989; 231():135-48. PubMed ID: 2488446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of N-acyl quinolin-2(1H)-ones as new selective agents against clinical isolates of Acanthamoeba keratitis.
    Reyes-Batlle M; Freijo MB; López-Arencibia A; Lorenzo-Morales J; McNaughton-Smith G; Piñero JE; Abad-Grillo T
    Bioorg Chem; 2020 Jun; 99():103791. PubMed ID: 32247111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of caspofungin on trophozoites and cysts of three species of Acanthamoeba.
    Bouyer S; Imbert C; Daniault G; Cateau E; Rodier MH
    J Antimicrob Chemother; 2007 Jan; 59(1):122-4. PubMed ID: 17079240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in the treatment of Acanthamoeba keratitis.
    Kumar R; Lloyd D
    Clin Infect Dis; 2002 Aug; 35(4):434-41. PubMed ID: 12145728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Vitro Comparison of the
    Redd TK; Talbott M; Cevallos V; Lalitha P; Seitzman GD; Lietman TM; Keenan JD
    Ophthalmol Sci; 2021 Jun; 1(2):100025. PubMed ID: 36249301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amoebicidal efficiencies of various diamidines against two strains of Acanthamoeba polyphaga.
    Perrine D; Chenu JP; Georges P; Lancelot JC; Saturnino C; Robba M
    Antimicrob Agents Chemother; 1995 Feb; 39(2):339-42. PubMed ID: 7726493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of magainins on ameba and cyst stages of Acanthamoeba polyphaga.
    Schuster FL; Jacob LS
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1263-71. PubMed ID: 1416825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acanthamoeba keratitis, a possible dibromo propamidine isethionate resistance].
    Vaquero Ruano M; Encinas Martín JL; Ramón Y Cajal S; Cajigal Morales C
    Arch Soc Esp Oftalmol; 2002 May; 77(5):279-81. PubMed ID: 12023748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of miltefosine for topical treatment of Acanthamoeba keratitis in Syrian hamsters.
    Polat ZA; Obwaller A; Vural A; Walochnik J
    Parasitol Res; 2012 Feb; 110(2):515-20. PubMed ID: 21748351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of chlorhexidine disinfectant in vitro effect on environmental and ocular Acanthamoeba strains, the amoebic agents of human keratitis − an emerging sight-threatening corneal disease in Poland.
    Padzik M; Baltaza W; Szaflik JP; Hendiger E; Dybicz M; Chomicz L
    Ann Parasitol; 2018; 64(3):229-233. PubMed ID: 30316219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro effectiveness of povidone-iodine on Acanthamoeba isolates from human cornea.
    Gatti S; Cevini C; Bruno A; Penso G; Rama P; Scaglia M
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2232-4. PubMed ID: 9736540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.